DiaMedica Therapeutics Inc. DMAC

Updated: 10 Aug 2026

NASDAQ | Biotech | Biotechnology

No signal published yet

We already track DiaMedica Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow DiaMedica Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology
We're already tracking DiaMedica Therapeutics Inc. — here are the latest events we've registered

Recent News

  • On August 4, 2026, DiaMedica Therapeutics announced that it will report its second quarter 2026 financial results after market close on August 10, 2026. In June 2026, the company dosed the first patients in a Phase 2 trial of DM199 for the treatment of fetal growth restriction.

What Firelda Watch includes for DiaMedica Therapeutics Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of DiaMedica Therapeutics Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Want to follow DiaMedica Therapeutics Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow DiaMedica Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

DiaMedica Therapeutics Inc. DMAC
DiaMedica Therapeutics — follow and we'll monitor it
Follow DiaMedica Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.